Manipulation of the physiology of clavulanic acid production in Streptomyces clavuligerus

References

1. Baldwin J.E., Goh K.-C., Schofield C.J. 1994; Biosynthetic precursors of valclavam.. Tetrahedron Lett 35:2779–2782
   [Google Scholar]
2. Bascaran V., Hardisson C., Braña A.F. 1989; Isolation and characterization of nitrogen-deregulated mutants of Streptomyces clavuligerus.. J Gen Microbiol 135:2475–2482
   [Google Scholar]
3. Brown A.G. 1986; Clavulanic acid, a novel β-lactamase inhibitor: a case study in drug discovery and development.. Drug Design Deliv 1:1–21
   [Google Scholar]
4. Bushell M.E. 1988; Growth, metabolism and fermentation technology.. In Biotechnology of the Actinomycetales pp. 185–215 Edited by Goodfellow M., Williams S. T., Mordarski M. London: Academic Press;
   [Google Scholar]
5. Bushell M.E., Bell S.L., Scott M. F., Spier R.E., Wardell J.N., Sanders P.G. 1994; Enhancement of monoclonal antibody yield by hybridoma fed-batch culture, resulting in extended maintenance of viable cell population.. Biotechnol Bioeng 44:1099–1106
   [Google Scholar]
6. Bushell M.E., Smith J., Lynch H.C. 1997; A physiological model for the control of erythromycin production in batch and cyclic fed batch culture.. Microbiology 143:475–480
   [Google Scholar]
7. Clark G.J., Langley D., Bushell M.E. 1995; Oxygen limitation can induce microbial secondary metabolite formation: investigations with miniature electrodes in shaker and bioreactor culture.. Microbiology 141:663–669
   [Google Scholar]
8. Foulstone M., Reading C. 1982; Assay of Amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high performance liquid chromatography.. Antimicrob Agents Chemother 22:753–762
   [Google Scholar]
9. Hopwood D.A. 1981; Genetic studies of antibiotics and other secondary metabolites.. In Genetics as a Tool in Microbiology (Symposia of the Society for General Microbiology vol. 31) pp. 187–218 Edited by Glover S.W., Hopwood D.A. Cambridge: Cambridge University Press;
   [Google Scholar]
10. Ives P.R. 1995 Physiological aspects of the production of clavulanic acid by Streptomyces clavuligerus. PhD thesis, University of Surrey.
    [Google Scholar]
11. Jones B.N., Paabo S., Stein S. 1981; Amino acid analysis and enzymatic sequence determination of peptides by an improved o-phthaldiamide precolumn labelling procedure.. J Liq Chromatogr 4:565–586
    [Google Scholar]
12. Joseph M.H., Marsden C.A. 1986; Amino acids and small peptides.. In HPLC of Small Molecules: a Practical Approach pp. 13–28 Edited by Lim C.K. Oxford: IRL Press;
    [Google Scholar]
13. Lynch H.C., Bushed M.E. 1995; The physiology of erythromycin biosynthesis in cyclic fed batch culture.. Microbiology 141:3105–3111
    [Google Scholar]
14. McDermott J.F., Lethbridge G., Bushell M.E. 1993; Estimation of the kinetic constants and elucidation of trends in growth and erythromycin production in batch and continuous cultures of Saccharopolyspora erythraea using curve fitting techniques.. Enzyme Microb Technol 15:657–663
    [Google Scholar]
15. Mendz G.L., Hazell S.L. 1996; The urea cycle of Helicobacter pylori.. Microbiology 142:2959–2967
    [Google Scholar]
16. Pirt S.J. 1975 Principles of Microbe and Cell Cultivation. Oxford: Blackwell Scientific Publications;
    [Google Scholar]
17. Pitlik J., Townsend C.A. 1997; The fate of [2,3,3-H-2(3), 1,2-C-13(2)]-d,l-glycerate in clavulanic acid.. J Chem Soc Chem Commun 2:225–226
    [Google Scholar]
18. Queener S., Swartz R. 1979; Penicillins; biosynthetic and semisynthetic.. In Economic Microbiology vol. 3,Secondary Products of Metabolism pp. 35–123 Edited by Rose A.H. London: Academic Press;
    [Google Scholar]
19. Reading C., Cole M. 1977; Clavulanic acid: a β-lactamase inhibiting β-lactam from Streptomyces clavuligerus.. Antimicrob Agents Chemother 11:852–857
    [Google Scholar]
20. Reed G., Peppier H.J. 1973 Yeast Technology pp. 664–668 Westport: AVI;
    [Google Scholar]
21. Romero J., Liras P., Martin J.F. 1984; Dissociation of cephamycin and clavulanic acid production in Streptomyces clavuligerus.. Appl Microbiol Biotechnol 20:318–325
    [Google Scholar]
22. Romero J., Liras P., Martin J.F. 1986; Utilisation of ornithine and arginine as specific precursors of clavulanic acid.. Appl Environ Microbiol 52:892–897
    [Google Scholar]
23. Stirling I., Elson S.W. 1979; Studies on the biosynthesis of clavulanic acid. II. Chemical degradations of ¹⁴C-labelled clavulanic acid.. J Antibiot 32:1125–1129
    [Google Scholar]
24. Townsend C. A., Ho M.-F. 1985a; Biosynthesis of clavulanic acid: origin of the C₅ unit.. J Am Chem Soc 107:1065–1066
    [Google Scholar]
25. Townsend C. A., Ho M.-F. 1985b; Biosynthesis of clavulanic acid: origin of the C₃ unit.. J Am Chem Soc 107:1066–1068
    [Google Scholar]
26. Umbarger H.E. 1978; Amino acid biosynthesis and its regulation.. Annu Rev Biochem 47:533–606
    [Google Scholar]
27. Valentine B.P., Bailey C.R., Doherty A., Morris J., Elson S.W., Baggaley K.H., Nicholson N.H. 1993; Evidence that arginine is a later metabolic intermediate than ornithine in the biosynthesis of clavulanic acid by Streptomyces clavuligerus.. J Chem Soc Chem Commun 15:1210–1211
    [Google Scholar]
28. Wilson G.C., Bushell M.E. 1995; The induction of antibiotic synthesis in Saccharopolyspora erythraea and Streptomyces hygroscopicus by growth rate decrease is accompanied by a down-regulation of protein synthesis rate.. FEMS Microbiol Lett 129:89–96
    [Google Scholar]